Literature DB >> 23911657

A glucose-6-phosphate isomerase peptide induces T and B cell-dependent chronic arthritis in C57BL/10 mice: arthritis without reactive oxygen species and complement.

Angela Pizzolla1, Kajsa Wing1, Rikard Holmdahl2.   

Abstract

Immunization with human glucose-6-phosphate isomerase (hG6PI) protein or with several of its peptides induces arthritis in DBA/1 mice. We investigated G6PI peptide-induced arthritis in C57BL/10 mice and the effect of oxidative burst on disease. To study the arthritogenicity of G6PI peptides and its immune dependency, we used genetically modified and congenic mice on the C57BL/10 background and in vitro T- and B-cell assays. hG6PI(325-339) peptide induced arthritis in C57BL/10 mice. The disease was associated with major histocompatibility complex class II and was dependent on T cells, B cells, and complement C5. Th1 and Th17 cells primed with the hG6PI(325-339) peptide cross-reacted with the murine G6PI protein. The severity of the disease increased in mice carrying a mutation in Ncf1 (Ncf1*/*), which abolishes the NADPH oxidase 2 complex oxidative burst. Ncf1*/* mice developed arthritis also on immunization with the mouse G6PI325-339 peptide and in the absence of C5. The antibody responses to the G6PI protein and peptides were minimal in both Ncf1*/* and wild-type mice. Herein is described G6PI peptide as the first peptide to induce arthritis in C57BL/10 mice. The differences between the wild-type and Ncf1*/* mice suggest that an alternative complement-independent arthritogenic pathway could be operative in the absence of oxidative burst.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911657     DOI: 10.1016/j.ajpath.2013.06.019

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

1.  Cryptococcus strains with different pathogenic potentials have diverse protein secretomes.

Authors:  Leona T Campbell; Anna R Simonin; Cuilan Chen; Jannatul Ferdous; Matthew P Padula; Elizabeth Harry; Markus Hofer; Iain L Campbell; Dee A Carter
Journal:  Eukaryot Cell       Date:  2015-04-03

2.  Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.

Authors:  Anthony C Y Yau; Fredrik Piehl; Tomas Olsson; Rikard Holmdahl
Journal:  Immunology       Date:  2016-12-22       Impact factor: 7.397

3.  Redox regulation of PTPN22 affects the severity of T-cell-dependent autoimmune inflammation.

Authors:  Jaime James; Yifei Chen; Clara M Hernandez; Florian Forster; Markus Dagnell; Qing Cheng; Amir A Saei; Hassan Gharibi; Gonzalo Fernandez Lahore; Annika Åstrand; Rajneesh Malhotra; Bernard Malissen; Roman A Zubarev; Elias S J Arnér; Rikard Holmdahl
Journal:  Elife       Date:  2022-05-19       Impact factor: 8.713

4.  Standardization of Antigen-Emulsion Preparations for the Induction of Autoimmune Disease Models.

Authors:  Louise M Topping; Laura Romero-Castillo; Vilma Urbonaviciute; Hans Bolinsson; Felix I Clanchy; Rikard Holmdahl; B Thomas Bäckström; Richard O Williams
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

5.  Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4.

Authors:  Min Yang; Katrin Klocke; Clara Marquina Hernandez; Bingze Xu; Inger Gjertsson; Kajsa Wing; Rikard Holmdahl
Journal:  Immunology       Date:  2018-07-31       Impact factor: 7.397

Review 6.  T-cell metabolism in autoimmune disease.

Authors:  Zhen Yang; Eric L Matteson; Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2015-02-11       Impact factor: 5.156

7.  Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation.

Authors:  Ulrika Norin; Carola Rintisch; Liesu Meng; Florian Forster; Diana Ekman; Jonatan Tuncel; Katrin Klocke; Johan Bäcklund; Min Yang; Michael Y Bonner; Gonzalo Fernandez Lahore; Jaime James; Klementy Shchetynsky; Maria Bergquist; Inger Gjertsson; Norbert Hubner; Liselotte Bäckdahl; Rikard Holmdahl
Journal:  Nat Commun       Date:  2021-01-27       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.